Adrian von Segesser
Director/Miembro de la Junta en ewl Energie Wasser Luzern Holding AG .
Perfil
Adrian von Segesser has worked as a Director at SpePharm AG and as a Member-Supervisory Board at ewl Energie Wasser Luzern Holding AG.
Cargos activos de Adrian von Segesser
| Empresas | Cargo | Inicio |
|---|---|---|
ewl Energie Wasser Luzern Holding AG
 ewl Energie Wasser Luzern Holding AG Alternative Power GenerationUtilities ewl Energie Wasser Luzern Holding AG engages in the generation and distribution of electricity. The firm’s services include electricity, gas, water, heat, telecommunications, and mobility. It also provides installation and energy consulting. The company was founded on December 18, 2000 and is headquartered in Lucerne, Switzerland. | Director/Miembro de la Junta | 01/01/2010 |
SpePharm AG
 SpePharm AG Pharmaceuticals: MajorHealth Technology SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
ewl Energie Wasser Luzern Holding AG
ewl Energie Wasser Luzern Holding AG Alternative Power GenerationUtilities ewl Energie Wasser Luzern Holding AG engages in the generation and distribution of electricity. The firm’s services include electricity, gas, water, heat, telecommunications, and mobility. It also provides installation and energy consulting. The company was founded on December 18, 2000 and is headquartered in Lucerne, Switzerland. | Utilities |
SpePharm AG
SpePharm AG Pharmaceuticals: MajorHealth Technology SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Adrian von Segesser
